Pathophysiology of Myocardial Infarction With Nonobstructive Coronary Artery Disease: A Contemporary Systematic

Laurie-Anne Boivin-Proulx1, Kevin Haddad2, Marco Lombardi3,4

  • 1Division of Cardiology, Interventional Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

CJC Open
|March 15, 2024
PubMed
Abstract

Insights

Myocardial infarction with nonobstructive coronary artery disease (MINOCA) requires a structured diagnostic approach to identify underlying causes. Understanding MINOCA pathophysiology is key for tailored therapies and improved patient outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathophysiology

Background:

  • Myocardial infarction with nonobstructive coronary artery disease (MINOCA) accounts for 6% of acute myocardial infarction (AMI) cases.
  • MINOCA is linked to increased mortality and morbidity.
  • The diverse causes of MINOCA pose diagnostic challenges.

Purpose of the Study:

  • To systematically review the pathophysiology of MINOCA.
  • To provide a contemporary understanding of MINOCA's underlying mechanisms.

Main Methods:

  • A systematic review of studies published after January 1, 2013, was conducted.
  • PubMed database was utilized to identify relevant systematic reviews, meta-analyses, RCTs, and cohort studies.
  • Studies were retained if they reported on MINOCA pathophysiology and were in English or French.

Main Results:

  • Eighty records were retained from 600 identified.
  • A structured approach is essential to rule out obstructive coronary artery disease and identify myocyte injury mechanisms.
  • Potential causes include plaque disruption, vasospasm, microvascular dysfunction, embolism, dissection, or supply-demand mismatch.

Conclusions:

  • Accurate definition of AMI and understanding MINOCA pathophysiology are crucial.
  • Effective multimodal diagnostic evaluation is necessary.
  • Tailored therapies based on specific causes improve patient management.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
645
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K